4//SEC Filing
SANTINI GINO 4
Accession 0001062993-25-014694
CIK 0001267565other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:10 PM ET
Size
11.2 KB
Accession
0001062993-25-014694
Insider Transaction Report
Form 4
SANTINI GINO
Director
Transactions
- Sale
Common Stock
2025-08-15$37.19/sh−5,405$201,018→ 95,042 total - Exercise/Conversion
Common Stock
2025-08-15$13.45/sh+15,000$201,750→ 100,447 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-08-15−15,000→ 0 totalExercise: $13.45Exp: 2025-09-10→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.17 to $37.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001276038
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:10 PM ET
- Size
- 11.2 KB